Clinical Trial

Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this research is to understand and treat Traumatic Brain Injury (TBI) associated photophobia (light sensitivity) and its impact on visual function.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09-30 -> 2027-09-30 2026-08-15
minor Completion pushed: 2026-09-30 -> 2027-09-30 2026-08-15
Trial Details
NCT Number NCT06293300
Lead Sponsor University of Miami
Collaborators: United States Department of Defense
Conditions Traumatic Brain Injury
Enrollment 50 participants
Start Date 2024-09-30
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14